Overview

A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

Status:
COMPLETED
Trial end date:
2024-09-13
Target enrollment:
Participant gender:
Summary
To assess the effect of BGM0504 injection versus placebo on weight loss in overweight or obese subjects after 24 weeks of treatment.
Phase:
PHASE2
Details
Lead Sponsor:
BrightGene Bio-Medical Technology Co., Ltd.